{"id":2014,"date":"2012-10-16T05:07:00","date_gmt":"2012-10-16T00:07:00","guid":{"rendered":"http:\/\/www.policymed.com\/physician-payment-sunshine-act-cbi-chart-the-state-of-sunshine\/"},"modified":"2018-05-06T17:46:27","modified_gmt":"2018-05-06T12:46:27","slug":"physician-payment-sunshine-act-cbi-chart-the-state-of-sunshine","status":"publish","type":"post","link":"https:\/\/www.policymed.com\/2012\/10\/physician-payment-sunshine-act-cbi-chart-the-state-of-sunshine.html","title":{"rendered":"Physician Payment Sunshine Act: CBI Chart &#8211; Shining Light on the Sunshine Act"},"content":{"rendered":"<p><span style=\"font-family: arial,helvetica,sans-serif;\">As we continue to wait for the final regulations from the Centers for Medicare &amp; Medicaid Services (CMS) to implement the Physician Payment Sunshine Act, several groups are getting creative to find ways to \u201cShine Light on the Sunshine Act.\u201d\u00a0 One recent example is a <a href=\"http:\/\/www.cbinet.com\/shining-light-sunshine-act?goback=.gde_714547_member_173922726#.UHth2K5dw2H\">chart<\/a> that CBI made that gives a detailed overview of the act and implementing regulations.\u00a0 The chart includes data and references to several recent Sunshine Act surveys we have reported over the past few months.\u00a0<\/span><\/p>\n<p><span style=\"font-family: arial,helvetica,sans-serif;\">One interesting statistic the chart should was current and future manufacturers\u2019 plans for health care spending caps in relation to the proposed Sunshine Act.\u00a0 These statistics are interesting because the sole purpose of the Sunshine act is to shed light on relationships between physicians and industry.\u00a0\u00a0<\/span><\/p>\n<ul>\n<li><span style=\"font-family: arial,helvetica,sans-serif;\">9% of companies are unsure about their spending<\/span><\/li>\n<li><span style=\"font-family: arial,helvetica,sans-serif;\">28% of companies said they have no spending caps<\/span><\/li>\n<li><span style=\"font-family: arial,helvetica,sans-serif;\">42% of companies expect to me PhRMA guidelines<\/span><\/li>\n<li><span style=\"font-family: arial,helvetica,sans-serif;\">21% of companies will exceed PhRMA guidelines\u00a0<\/span><\/li>\n<\/ul>\n<p><span style=\"font-family: arial,helvetica,sans-serif;\">For companies who are currently tracking spending\u00a0<\/span><\/p>\n<ul>\n<li><span style=\"font-family: arial,helvetica,sans-serif;\">9% track only physicians<\/span><\/li>\n<li><span style=\"font-family: arial,helvetica,sans-serif;\">14% track only prescribers<\/span><\/li>\n<li><span style=\"font-family: arial,helvetica,sans-serif;\">23% track all licensed healthcare professionals<\/span><\/li>\n<li><span style=\"font-family: arial,helvetica,sans-serif;\">52% track all healthcare professionals\u00a0<\/span><\/li>\n<\/ul>\n<p><span style=\"font-family: arial,helvetica,sans-serif;\">The chart also shows which entities manufacturers consider covered under educational and philanthropic grants during transparency reporting:\u00a0<\/span><\/p>\n<ul>\n<li><span style=\"font-family: arial,helvetica,sans-serif;\">14% don\u2019t know<\/span><\/li>\n<li><span style=\"font-family: arial,helvetica,sans-serif;\">4% multiple entities<\/span><\/li>\n<li><span style=\"font-family: arial,helvetica,sans-serif;\">6% educational partner<\/span><\/li>\n<li><span style=\"font-family: arial,helvetica,sans-serif;\">39% payee<\/span><\/li>\n<li><span style=\"font-family: arial,helvetica,sans-serif;\">4% requestor<\/span><\/li>\n<li><span style=\"font-family: arial,helvetica,sans-serif;\">6% LOA signatory\u00a0<\/span><\/li>\n<\/ul>\n<p><span style=\"font-family: arial,helvetica,sans-serif;\">Current motivations for transparency reporting for manufacturers include (2011\/2010):\u00a0<\/span><\/p>\n<ul>\n<li><span style=\"font-family: arial,helvetica,sans-serif;\">Voluntary (27%\/26%)<\/span><\/li>\n<li><span style=\"font-family: arial,helvetica,sans-serif;\">Not engaged in transparency reporting (53%\/55%)<\/span><\/li>\n<li><span style=\"font-family: arial,helvetica,sans-serif;\">CIA mandated (16%\/7%)<\/span><\/li>\n<li><span style=\"font-family: arial,helvetica,sans-serif;\">Report scope beyond CIA requirements (4%\/12%)\u00a0<\/span><\/li>\n<\/ul>\n<p><span style=\"font-family: arial,helvetica,sans-serif;\">The chart correctly notes that when payments are published online at a public website, there is a significant potential for unintended consequences.\u00a0 For example, the information could be misleading, which would lead to negative repurtations that could manipulate market perception.\u00a0 Moreover, large legitimate payments, necessary for the development of all drugs, could be mistrued as improper gifts.\u00a0 The chart also recognizes that policies by healthcare organizations, as a result of the increased scrutiny of physician-industry relationships caused by the Sunshine Act, could prohibit teaching hospitals from working with life-sciences manufacturers.\u00a0 This will potentially limit manufacturers\u2019 interpretation with physicians, which will result in physicians being unaware of new drugs.\u00a0\u00a0\u00a0<\/span><\/p>\n<p><span style=\"font-family: arial,helvetica,sans-serif;\">The chart shows that companies plan to report convention booth interactions with healthcare providers in the following ways:\u00a0<\/span><\/p>\n<ul>\n<li><span style=\"font-family: arial,helvetica,sans-serif;\">38% capture all resultant spend<\/span><\/li>\n<li><span style=\"font-family: arial,helvetica,sans-serif;\">9% capture only items that exceed a set value<\/span><\/li>\n<li><span style=\"font-family: arial,helvetica,sans-serif;\">4% have no plans to capture resultant spend<\/span><\/li>\n<li><span style=\"font-family: arial,helvetica,sans-serif;\">9% are not providing items of value<\/span><\/li>\n<li><span style=\"font-family: arial,helvetica,sans-serif;\">38% don\u2019t know\u00a0<\/span><\/li>\n<\/ul>\n<p><span style=\"font-family: arial,helvetica,sans-serif;\">Companies plan to validate their data before public disclosure in the following ways:\u00a0<\/span><\/p>\n<ul>\n<li><span style=\"font-family: arial,helvetica,sans-serif;\">11% no validation<\/span><\/li>\n<li><span style=\"font-family: arial,helvetica,sans-serif;\">18% internal certification<\/span><\/li>\n<li><span style=\"font-family: arial,helvetica,sans-serif;\">2% doctors validate<\/span><\/li>\n<li><span style=\"font-family: arial,helvetica,sans-serif;\">40% system validation \/ audit process<\/span><\/li>\n<li><span style=\"font-family: arial,helvetica,sans-serif;\">7% other\u00a0<\/span><\/li>\n<\/ul>\n<p><span style=\"font-family: arial,helvetica,sans-serif;\">With respect to how manufactures intent to notify healthcare providers of their transparency intentions:\u00a0<\/span><\/p>\n<ul>\n<li><span style=\"font-family: arial,helvetica,sans-serif;\">20% have produced and distributed communication materials<\/span><\/li>\n<li><span style=\"font-family: arial,helvetica,sans-serif;\">43% plan to produce and distribute communication materials<\/span><\/li>\n<li><span style=\"font-family: arial,helvetica,sans-serif;\">9% have no plans<\/span><\/li>\n<li><span style=\"font-family: arial,helvetica,sans-serif;\">28% are unsure\u00a0<\/span><\/li>\n<\/ul>\n<p><span style=\"font-family: arial,helvetica,sans-serif;\">Finally, the chart shows how involved parties:\u00a0\u00a0<\/span><\/p>\n<ul>\n<li><span style=\"font-family: arial,helvetica,sans-serif;\">18% of manufacturers and HCPs find developing new procedures for justifying physician payments and ensuring the accurate reports of spending difficult<\/span><\/li>\n<li><span style=\"font-family: arial,helvetica,sans-serif;\">32% somewhat difficult<\/span><\/li>\n<li><span style=\"font-family: arial,helvetica,sans-serif;\">50% not difficult\u00a0<\/span><\/li>\n<\/ul>\n<p><span style=\"font-family: arial,helvetica,sans-serif;\">With respect to how much change in the reporting process the Sunshine act will require:<\/span><\/p>\n<ul>\n<li><span style=\"font-family: arial,helvetica,sans-serif;\">17% expect significant change<\/span><\/li>\n<li><span style=\"font-family: arial,helvetica,sans-serif;\">45% moderate change<\/span><\/li>\n<li><span style=\"font-family: arial,helvetica,sans-serif;\">2% no change<\/span><\/li>\n<li><span style=\"font-family: arial,helvetica,sans-serif;\">26% not currently doing any reporting\u00a0<\/span><\/li>\n<\/ul>\n<p><span style=\"font-family: arial,helvetica,sans-serif;\">With respect to whether education of all stakeholders are necessary.\u00a0<\/span><\/p>\n<ul>\n<li><span style=\"font-family: arial,helvetica,sans-serif;\">75% are doing software upgrades<\/span><\/li>\n<li><span style=\"font-family: arial,helvetica,sans-serif;\">12% are training employees<\/span><\/li>\n<li><span style=\"font-family: arial,helvetica,sans-serif;\">13% are hiring employees\/consultants.\u00a0\u00a0\u00a0<\/span><\/li>\n<\/ul>\n<p><span style=\"font-family: arial,helvetica,sans-serif;\">Overall the chart shows that Sunshine like the sun will take a lot of energy.\u00a0 Perhaps some of that energy will be taken away from research and in the end some patient will suffer as a result of the reallocation of resources. \u00a0\u00a0But we will never see it directly.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>As we continue to wait for the final regulations from the Centers for Medicare &amp; Medicaid Services (CMS) to implement the Physician Payment Sunshine Act, several groups are getting creative to find ways to \u201cShine Light on the Sunshine Act.\u201d\u00a0 One recent example is a chart that CBI made that gives a detailed overview of [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":9621,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[33,51],"tags":[1101],"class_list":["post-2014","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-open-payments","category-physician-payment-sunshine-act","tag-new"],"_links":{"self":[{"href":"https:\/\/www.policymed.com\/wp-json\/wp\/v2\/posts\/2014","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.policymed.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.policymed.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.policymed.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.policymed.com\/wp-json\/wp\/v2\/comments?post=2014"}],"version-history":[{"count":2,"href":"https:\/\/www.policymed.com\/wp-json\/wp\/v2\/posts\/2014\/revisions"}],"predecessor-version":[{"id":9625,"href":"https:\/\/www.policymed.com\/wp-json\/wp\/v2\/posts\/2014\/revisions\/9625"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.policymed.com\/wp-json\/wp\/v2\/media\/9621"}],"wp:attachment":[{"href":"https:\/\/www.policymed.com\/wp-json\/wp\/v2\/media?parent=2014"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.policymed.com\/wp-json\/wp\/v2\/categories?post=2014"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.policymed.com\/wp-json\/wp\/v2\/tags?post=2014"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}